Is it Time for a Federal "Vaccines for Adults" Program?

Slideshow

Would a program for US adults who are uninsured or underinsured help increase uptake rates for recommended immunizatons, for example, against influenza and pneumococcal disease? Would it make economic sense?

Terry Brenneman, MD
Terry Brenneman, MD

I read a June 21, 2023 Perspective feature in the New England Journal of Medicine written by scientists from the Centers for Disease Control and Prevention and the the National Center for Immunization and Respiratory Diseases that answers the question comprehensively and clearly. This short slide show-plus-quiz-questions higlights their thoughts. A hyperlink to the full article is below.

Wallender E, Peacock G, Wharton M, Walensky RP. Uninsured and not immune--closing the vaccine-coverage gap for adults. N Engl J Med. Published online June 21, 2023. doi:10.1056/NEJMp2306200

Recent Videos
"Vaccination is More of a Marathon than a Sprint"
Vaccines are for Kids, Booster Fatigue, and Other Obstacles to Adult Immunization
Interview with Kelly Moore, MD, MPH, president, chief executive officer, Immunization Action Coalition
Related Content
FDA Reviewing New Prefilled Syringe Formulation for GSK’s Shingrix / image credit ©Sherry Young/stock.adobe.com

FDA Reviewing New Prefilled Syringe Formulation for GSK’s Shingrix

Patient Care Staff
January 13th 2025
Article

An FDA decision on GSK's Shingrix application is expected by June 20, 2025.

Primary Viewpoints: Immunizations with Dr Steven P. Furr

Primary Viewpoints: Immunizations with Dr Steven P. Furr

Keith A. Reynolds
October 1st 2024
Podcast

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Steven P. Furr, former president of the American Academy of Family Physicians.

Bird Flu: First US Death Reported, NIH Updates Risk Assessment

Bird Flu: First US Death Reported, NIH Updates Risk Assessment

John Parkinson;Grace Halsey
January 7th 2025
Article

The first death of an American from the H5N1 virus was reported in Louisiana on Monday, though authorities maintain the risk of widespread infection remains low.

Respiratory Tripledemic 2022-23: An Expert Recap

Respiratory Tripledemic 2022-23: An Expert Recap

Sydney Jennings
April 6th 2023
Podcast

William Schaffner, MD, medical director of the NFID, provides an expert recap of the 2022-2023 respiratory virus season for primary care clinicians.

CDC Adds Heplisav-B to Recommendations for HepB Vaccination During Pregnancy / image credit ©Dmitry Naumov/stock.adobe.com

CDC Adds Heplisav-B to Recommendations for HepB Vaccination During Pregnancy

Grace Halsey
December 18th 2024
Article

The addition, based on an approved update to labeling, expands to 4 the recommended vaccination options that health care professionals can offer to pregnant people.

Sanofi Investigational COVID-19/Influenza Combination Vaccines Granted FDA Fast-Track Designation / image credit ©Katyeryna_Kon/shutterstock.com

Sanofi Investigational COVID-19/Influenza Combination Vaccines Granted FDA Fast-Track Designation

Grace Halsey
December 18th 2024
Article

The 2 novel vaccine candidates each combine a Sanofi licensed influenza vaccine with the Novavax adjuvanted recombinant COVID-19 vaccine.

© 2025 MJH Life Sciences

All rights reserved.